1-167685482-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_052862.4(RCSD1):āc.170A>Gā(p.Lys57Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000266 in 1,613,690 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_052862.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RCSD1 | NM_052862.4 | c.170A>G | p.Lys57Arg | missense_variant | 3/7 | ENST00000367854.8 | NP_443094.3 | |
RCSD1 | NM_001322923.2 | c.108+1481A>G | intron_variant | NP_001309852.1 | ||||
RCSD1 | NM_001322924.2 | c.108+1481A>G | intron_variant | NP_001309853.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RCSD1 | ENST00000367854.8 | c.170A>G | p.Lys57Arg | missense_variant | 3/7 | 1 | NM_052862.4 | ENSP00000356828.3 | ||
RCSD1 | ENST00000537350.5 | c.108+1481A>G | intron_variant | 1 | ENSP00000439409.1 | |||||
RCSD1 | ENST00000361496.3 | c.170A>G | p.Lys57Arg | missense_variant | 3/5 | 3 | ENSP00000355291.3 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152018Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000281 AC: 41AN: 1461672Hom.: 0 Cov.: 30 AF XY: 0.0000234 AC XY: 17AN XY: 727138
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152018Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74246
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 05, 2024 | The c.170A>G (p.K57R) alteration is located in exon 3 (coding exon 3) of the RCSD1 gene. This alteration results from a A to G substitution at nucleotide position 170, causing the lysine (K) at amino acid position 57 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at